Robert Kristal - Feb 17, 2023 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
Chief Financial Officer
Signature
/s/ Robert Kristal
Stock symbol
BRTX
Transactions as of
Feb 17, 2023
Transactions value $
$0
Form type
4
Date filed
2/17/2023, 04:32 PM
Previous filing
Nov 4, 2022
Next filing
Feb 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BRTX Common Stock 7.99K Feb 17, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRTX Stock Option Award $0 +89K $0.00 89K Feb 17, 2023 Common Stock 89K $2.91 Direct F2
holding BRTX Stock Option 10.5K Feb 17, 2023 Common Stock 10.5K $5.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested.
F2 The option vests and becomes exercisable to the extent of 44,484 shares on February 17, 2023 with the remaining 44,484 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested.